Addressing the Barriers to Pediatric Drug Development:...

Main
Medicine
Addressing the Barriers to Pediatric...

Addressing the Barriers to Pediatric Drug Development: Workshop Summary

Development, and Translation Forum on Drug Discovery, Institute of Medicine

0 / 0

Насколько вам понравилась эта книга?

Какого качества скаченный файл?

Скачайте книгу, чтобы оценить ее качество

Какого качества скаченные файлы?

Категории:

Год:

2008

Язык:

english

Страницы:

64

ISBN 10:

0309107431

ISBN 13:

9780309107433

Файл:

PDF, 375 KB

IPFS:

,

english, 2008

Читать Онлайн

Выполняется конвертация в

Конвертация в не удалась

Вас может заинтересовать

Development, and Translation Forum on Drug Discovery, Institute of Medicine — Accelerating the Development of Biomarkers for Drug Safety: Workshop Summary

Andrew E. Mulberg, Steven A. Silber, John N. van den Anker — Pediatric Drug Development: Concepts and Applications (v. 1)

Brown, Nathan; [Brown, Nathan] — Artificial Intelligence in Drug Discovery

Gupte S., Gupte N., Smith R. — Pediatric Drug Directory

Theresa Wizeman, Sally Robinson, Robert Giffin, Development, and Translation Forum on Drug Discovery, Institute of Medicine — Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary

Linda Skidmore-Roth — Mosby’s 2019 Nursing Drug Reference E-Book

Ahmed F. Abdel-Magid, Stéphane Caron — Fundamentals of Early Clinical Drug Development: From Synthesis Design to Formulation

Ian K. M. Morton, Judith M. Hall — Concise Dictionary of Pharmacological Agents - Properties and Synonyms

United Nations Office for Drug Control and Crime Prevention — Developing An Integrated Drug Information System: Global Assessment Programme On Drug Abuse: Toolkit Module 1

Committee on Shortening the Time Line for New Cancer Treatments, Institute of Medicine and the National Research Council — Making Better Drugs for Children with Cancer

Richard A. Guarino — New Drug Approval Process 3rd Edition: The Global Challenge (Drugs and the Pharmaceutical Sciences)

Scott Patterson, Byron Jones — Bioequivalence and Statistics in Clinical Pharmacology (Interdisciplinary Statistics Series)

C. Sahajwalla — New Drug Devel. - Regul. Paradigms for Clin. Pharma and Biopharma

FDA/CDER/phanm — General Clinical Pharmacology Considerations for Pediatric Studies for Drugs and Biological Products

FDA/CDER/phanm — General Clinical Pharmacology Considerations for Pediatric Studies for Drugs and Biological Products

FDA/CDER/phanm — General Clinical Pharmacology Considerations for Pediatric Studies for Drugs and Biological Products. Guidance for Industry

FDA/CDER/phanm — General Clinical Pharmacology Considerations for Pediatric Studies for Drugs and Biological Products

Regulatory Affairs Professionals Society. — Fundamentals of Pharmaceutical and Biologics Regulations Volume I

Joseph F. Goldberg & Carrie L. Ernst — Managing the Side Effects of Psychotropic Medications

Divya Vohora; Gursharan Singh — Pharmaceutical Medicine and Translational Clinical Research

Odilia Osakwe, Syed A.A. Rizvi PhD PhD MSc MBA MS MRSC — Social Aspects of Drug Discovery, Development and Commercialization

Ira R. Berry — Introduction to the Pharmaceutical Regulatory Process

Cohen, I. Glenn; Lynch, Holly Fernandez — FDA in the twenty-first century : the challenges of regulating drugs and new technologies

Holly Fernandez Lynch (editor); I. Glenn Cohen (editor) — FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies

Board on Chemical Science and Technology and National Research Council — Rational Therapeutics for Infants and Children: Workshop Summary

Institute of Medicine — The Public Health Emergency Medical Countermeasures Enterprise: Innovative Strategies to Enhance Products from Discovery Through Approval: Workshop Summary

Institute of Medicine; Board on Population Health and Public Health Practice; Roundtable on Health Literacy; Cori Vancheri — The Safe Use Initiative and Health Literacy: Workshop Summary

Institute of Medicine; Board on Health Sciences Policy; and Translation Development Forum on Drug Discovery; Anne B. Claiborne; Steve Olson — Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development : Workshop Summary

Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA), Institute of Medicine, Marilyn J. Field, Thomas F. Boat — Safe and Effective Medicines for Children: Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act

Institute of Medicine; Board on Health Sciences Policy; and Translation Development Forum on Drug Discovery; Forum on Neuroscience and Nervous System Disorders; Clare Stroud; Christopher DeFeo; Evelyn Strauss; Sheena M. Posey Norris — Financial Incentives to Encourage Development of Therapies That Address Unmet Medical Needs for Nervous System Disorders: Workshop Summary

Lionel D. Edwards, Andrew J. Fletcher, Anthony W. Fox, Peter D. Stonier — Principles and Practice of Pharmaceutical Medicine

Alan M. Hoberman, Elise M. Lewis — Pediatric Non-Clinical Drug Testing: Principles, Requirements, and Practice

Brian L. Strom, Stephen E. Kimmel, Sean Hennessy — Pharmacoepidemiology, Fifth Edition

William J Brock; Kenneth L Hastings — Nonclinical safety assessment : a guide to international pharmaceutical regulations

Andrew J. Fletcher, Lionel D. Edwards, Anthony W. Fox, Peter D. Stonier — Practice and Principles of Pharmaceutical Medicine

Thomas M. Jacobsen, Albert I. Wertheimer — Modern Pharmaceutical Industry: A Primer

Arthur A. Daemmrich — Pharmacopolitics: Drug Regulation in the United States and Germany

Cynthia A Connolly — Children and Drug Safety: Balancing Risk and Protection in Twentieth-Century America

Cynthia A Connolly — Children and Drug Safety : Balancing Risk and Protection in Twentieth-Century America

Cynthia A Connolly [Connolly, Cynthia A] — Children and Drug Safety: Balancing Risk and Protection in Twentieth Century America

Cato — Clinical Drug Trials and Tribulations, Second Edition, (Drugs and the Pharmaceutical Sciences)

Richard A. Guarino — New Drug Approval Process Accelerating Global Registrations

Ключевые слова